share_log

Fusion Pharmaceuticals, BWXT Medical Announce Actinium-225 Partnership To Scale Supply For Developing Targeted Alpha Therapies

Benzinga Real-time News ·  Jan 5, 2023 17:04
Fusion Pharmaceuticals, BWXT Medical Announce Actinium-225 Partnership To Scale Supply For Developing Targeted Alpha Therapies
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment